In CRC, higher serum Gal-3 concentrations were observed in patients with more advanced TNM stages and Duke’s stages, as well as higher carcinoembryonic antigen (CEA) levels and venous invasion [8]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.